Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a ...
56mon MSN
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
July 15 (Reuters) - Taiwan-based contract drugmaker Bora Pharmaceuticals will partner with Insilico Medicine on a collaboration aimed at improving efficiency, potentially valued at more than $2.5 ...
With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...
The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined ...
The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum opened at Beijing Changping Future Science City on July 12. A Media Snippet ...
However, the rapid rise of automation, fintech integration, and data-driven manufacturing is transforming pharma production ...
Fragmented plant data across silos drives late investigations and corrective action; connected architectures unify PAT, sensors, batch, quality, and maintenance signals to enable earlier risk ...
Following a major push by the industry’s heavyweights to simplify their businesses in recent years, Tanabe Pharma is | While ...
The pharmaceutical industry is reaching a turning point in patient support. | Life sciences leaders say patient support is ...
Indian pharma set to transition from scale-led production to precision-driven manufacturing: Anurag Kumar: Nandita Vijayasimha, Bengaluru Tuesday, July 14, 2026, 08:00 Hrs [IST] I ...
Industry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will ...
Indian pharma is entering its next growth phase as a new segment gains traction. We analyse four companies building this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results